Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079332279> ?p ?o ?g. }
- W2079332279 endingPage "321" @default.
- W2079332279 startingPage "313" @default.
- W2079332279 abstract "Alan Saltiel and his colleagues report that the approved drug amlexanox, currently used to treat asthma and canker sores, is a relatively specific inhibitor of the noncanonical IκB kinases IKK-ɛ and TANK-binding kinase 1 (TBK1) and that it improves metabolic disease in mouse genetic and dietary models of obesity. These results suggest this drug may be repurposed to treat obesity and insulin resistance. Emerging evidence suggests that inflammation provides a link between obesity and insulin resistance. The noncanonical IκB kinases IKK-ɛ and TANK-binding kinase 1 (TBK1) are induced in liver and fat by NF-κB activation upon high-fat diet feeding and in turn initiate a program of counterinflammation that preserves energy storage. Here we report that amlexanox, an approved small-molecule therapeutic presently used in the clinic to treat aphthous ulcers and asthma, is an inhibitor of these kinases. Treatment of obese mice with amlexanox elevates energy expenditure through increased thermogenesis, producing weight loss, improved insulin sensitivity and decreased steatosis. Because of its record of safety in patients, amlexanox may be an interesting candidate for clinical evaluation in the treatment of obesity and related disorders." @default.
- W2079332279 created "2016-06-24" @default.
- W2079332279 creator A5007671828 @default.
- W2079332279 creator A5010060367 @default.
- W2079332279 creator A5018176504 @default.
- W2079332279 creator A5019976583 @default.
- W2079332279 creator A5024040432 @default.
- W2079332279 creator A5032715719 @default.
- W2079332279 creator A5042968595 @default.
- W2079332279 creator A5048186018 @default.
- W2079332279 creator A5049828619 @default.
- W2079332279 creator A5056064034 @default.
- W2079332279 creator A5057108969 @default.
- W2079332279 creator A5075001959 @default.
- W2079332279 creator A5080817693 @default.
- W2079332279 creator A5086779722 @default.
- W2079332279 creator A5087519016 @default.
- W2079332279 creator A5087598197 @default.
- W2079332279 creator A5090903923 @default.
- W2079332279 creator A5091832115 @default.
- W2079332279 date "2013-02-10" @default.
- W2079332279 modified "2023-09-30" @default.
- W2079332279 title "An inhibitor of the protein kinases TBK1 and IKK-ɛ improves obesity-related metabolic dysfunctions in mice" @default.
- W2079332279 cites W1631449371 @default.
- W2079332279 cites W1967724716 @default.
- W2079332279 cites W1971434116 @default.
- W2079332279 cites W1982652661 @default.
- W2079332279 cites W1982683121 @default.
- W2079332279 cites W1990172752 @default.
- W2079332279 cites W1991401793 @default.
- W2079332279 cites W1997071064 @default.
- W2079332279 cites W1998493448 @default.
- W2079332279 cites W2010911569 @default.
- W2079332279 cites W2010957046 @default.
- W2079332279 cites W2018135697 @default.
- W2079332279 cites W2019384852 @default.
- W2079332279 cites W2023794522 @default.
- W2079332279 cites W2033863085 @default.
- W2079332279 cites W2034640340 @default.
- W2079332279 cites W2037566407 @default.
- W2079332279 cites W2043892945 @default.
- W2079332279 cites W2047745287 @default.
- W2079332279 cites W2055421595 @default.
- W2079332279 cites W2059261163 @default.
- W2079332279 cites W2060915586 @default.
- W2079332279 cites W2063548806 @default.
- W2079332279 cites W2073656642 @default.
- W2079332279 cites W2084224574 @default.
- W2079332279 cites W2085328161 @default.
- W2079332279 cites W2085667526 @default.
- W2079332279 cites W2086073611 @default.
- W2079332279 cites W2089162704 @default.
- W2079332279 cites W2090457486 @default.
- W2079332279 cites W2090556647 @default.
- W2079332279 cites W2094296565 @default.
- W2079332279 cites W2100236190 @default.
- W2079332279 cites W2101328621 @default.
- W2079332279 cites W2107674876 @default.
- W2079332279 cites W2110630581 @default.
- W2079332279 cites W2111793830 @default.
- W2079332279 cites W2114041992 @default.
- W2079332279 cites W2130495917 @default.
- W2079332279 cites W2130874539 @default.
- W2079332279 cites W2131094572 @default.
- W2079332279 cites W2134888531 @default.
- W2079332279 cites W2138504016 @default.
- W2079332279 cites W2139203772 @default.
- W2079332279 cites W2140967704 @default.
- W2079332279 cites W2145697808 @default.
- W2079332279 cites W2146957741 @default.
- W2079332279 cites W2150702412 @default.
- W2079332279 cites W2154993634 @default.
- W2079332279 cites W2156280702 @default.
- W2079332279 cites W2156414024 @default.
- W2079332279 cites W2165334726 @default.
- W2079332279 cites W2165604976 @default.
- W2079332279 cites W2168531121 @default.
- W2079332279 cites W2171290692 @default.
- W2079332279 cites W2171716002 @default.
- W2079332279 cites W2176476208 @default.
- W2079332279 cites W4246592598 @default.
- W2079332279 cites W4249727000 @default.
- W2079332279 doi "https://doi.org/10.1038/nm.3082" @default.
- W2079332279 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3594079" @default.
- W2079332279 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23396211" @default.
- W2079332279 hasPublicationYear "2013" @default.
- W2079332279 type Work @default.
- W2079332279 sameAs 2079332279 @default.
- W2079332279 citedByCount "351" @default.
- W2079332279 countsByYear W20793322792013 @default.
- W2079332279 countsByYear W20793322792014 @default.
- W2079332279 countsByYear W20793322792015 @default.
- W2079332279 countsByYear W20793322792016 @default.
- W2079332279 countsByYear W20793322792017 @default.
- W2079332279 countsByYear W20793322792018 @default.
- W2079332279 countsByYear W20793322792019 @default.
- W2079332279 countsByYear W20793322792020 @default.
- W2079332279 countsByYear W20793322792021 @default.